Electromyography Devices Market Poised for Notable US$ 1,753 Million Valuation by 2033 – FMI Projection

The Electromyography Devices Market is expected to grow at a healthy 6.8% CAGR between 2023 and 2033. In 2023, the market is expected to be worth US$ 908 million, with a market share of US$ 1,753 million by 2033.

• The rising elderly population and more people with heart issues due to idle lifestyles and eating disorders contribute to market growth. More people with high cholesterol levels and chronic diseases like diabetes require constant monitoring. Hence, like ECG, electromyography (EMG) tests are also needed to detect neuromuscular abnormalities.
• A new device with higher sensory technology is inserted through an electrode needle in the muscle for the muscle health diagnosis. The device also becomes important for nerve health monitoring because it reveals nerve dysfunction and nerve-to-muscle transmission.
• These devices perform different electromyography as the procedure is segmented into three subtypes: mono-polar single electrodes, single-fiber EMG electrodes, and concentric-EMG electrodes. The variety of these devices serves different purposes in monitoring nerve and muscle health. More hospitals and healthcare centers are deploying these advanced machines to help patients get diagnosed properly before the treatment.
• The electrode (Needle) also has two subtypes: Surface (Skin Electrodes) and inserted electrodes. The recent spike in nerve-based issues such as strokes and nerve-based brain abnormalities has fueled the adoption of EMG devices for better research and development.
• The government building more hospitals with specific neuro and nerve-based sections is also adding value to the EMG testing and the devices used.

Get a Sample Copy of the Report :
https://www.futuremarketinsights.com/reports/sample/rep-gb-3971

Key Points

1. The United States market leads the North American electromyography devices market in terms of market share in North America. The United States held a leading market share of 35.7% in 2022. The factors attributed to the growth are world-class healthcare systems, higher technological penetration in healthcare systems, higher bandwidth internet, and integration of smart technologies. The North American region held a market share of 38.4% of the global market in 2022.
2. The German electromyography devices market held a healthy market share of 11.1% in 2022. The market growth is caused by the government’s focus on public health and innovation. The increasing geriatric population is also putting healthcare authorities on their toes to upgrade their systems with the recent versions. The European region accounted for a fair share of 29.2% of the global EMG devices market in 2022.
3. The Indian market thrives at a healthy CAGR of 7.8% between 2023 and 2033. The growth is attributed to the country building new multi-specialty hospitals and renovating their healthcare systems.
4. China’s electromyography market thrives at a CAGR of 8.3% between 2023 and 2033.
5. Based on modality, the standalone devices lead the segment as it held a market share of 71.1% in 2022.
6. Based on end-user type, the hospital segment aces the category as it held a market share of 42.1% in 2022.

Competitive Landscape

The key suppliers focus on advanced sensors and electrodes for detailed diagnosis and easy installation of the devices. The competitors also merge, acquire, and partner with other companies to increase their supply chain and distribution channel.

Recent Market Developments

• Cadwell Laboratories Inc. introduced customizable EMG devices with various carts. The end users can build their own EMG set-up, from monitors and computers to different sensors and needles.
• Natus Medical Inc. introduced its Ultrapro S100 EMG Neurodiagnostic system with superior signal quality enhanced assessments and easy controls.